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Edited by Laszlo NagyAbstract Human chitotriosidase is speciﬁcally expressed by
phagocytes, has anti-fungal activity towards chitin-containing
fungi in vitro and in vivo, and is part of innate immunity. We
studied the eﬀect of toll-like receptor (TLR)- and nucleotide-
binding oligomerization domain (NOD)-2 triggering on chitotri-
osidase expression and release by phagocytes. We ﬁnd that TLR,
but not NOD2 activation, regulates chitotriosidase release by
neutrophils. Furthermore, both TLR and NOD2 activation
resulted in diminished induction by monocytes. Lastly, NOD2
activation, but not TLR stimulation, induces chitinase expression
in macrophages. We conclude that phagocyte-speciﬁc regulation
is important for eﬃcient eradication of chitin-containing patho-
gens.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Human chitotriosidase, a phagocyte-speciﬁc chitinase, con-
tributes to innate immune responses by dint of anti-fungal
activity towards chitin-containing fungi, both in vitro and
in vivo [1,2]. The enzyme was ﬁrst described in Gaucher disease
patients, subsequently puriﬁed from a patient spleen and
cloned from a human macrophage (m/) cDNA library [3–6].
It is also present in human neutrophil speciﬁc granules which
release it upon stimulation [2,7]. This endoglucosaminidase be-
longs to the family 18 of glycosylhydrolases and cleaves chitin,
the linear polymer of N-acetyl-D-glucosamine coating many
pathogens such as protozoan parasites, fungi and nematodes
[8–10]. A close chitotriosidase relative is acid mammalian chi-
tinase (AMCase) [10].
Recently, it was shown that chitin induces the accumulation
of IL-4-expressing innate immune cells in mice. Alternative
activation of m/s occurred, with concomitant production ofAbbreviations: AMCase, acid mammalian chitinase; AML, acute
myeloid leukemia; m/, macrophage; MDP, muramyl dipeptide;
NOD, nucleotide-binding oligomerization domain; pGN, peptidogly-
can; TLR, toll-like receptor
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doi:10.1016/j.febslet.2007.10.039leukotriene B4, which was required for optimal immune cell
recruitment [11]. Expression of chitotriosidase and AMCase
diﬀers between man and rodents, however [12].
Innate and adaptive immunity combat pathogens by
discriminating between self and non-self. Mammalian innate
immune recognition, e.g. occurs via toll-like receptors (TLR)
and intracellular nucleotide-binding oligomerization domain
(NOD) proteins [13,14].
Chitotriosidase deﬁciency, due to a 24 bp insertion in exon
10, is found in 5% of the Western population [15]. Recently,
it was shown that genetic variants of this allele, severely com-
promising chitotriosidase activity, correlate with a higher risk
for Gram-negative infection in children undergoing therapy
for acute myeloid leukemia (AML) [16]. Chitotriosidase in-
crease was also detected in sera from neonates suﬀering bacte-
rial infections [17].
As these pathogens can be sensed through TLR and NOD,
we studied whether TLR and/or NOD2-derived signals inﬂu-
enced human phagocytic chitotriosidase expression and re-
lease. First, human neutrophilic enzyme release following
TLR and NOD2 stimulation was studied. Second, the eﬀect
of TLR and NOD2 triggering on monocytes and m/ was ana-
lysed.2. Materials and methods
2.1. Isolation of human phagocytes and culture conditions
Monocytes and neutrophils were isolated and cultured as described
[2]. Monocytes were cultured for 8 days in RPMI 1640 (BioWhittaker,
Viviers, Belgium) supplemented with 10% human serum (HS) (Bio-
Whittaker) in the presence or absence of TLR ligands or the NOD-2
ligand muramyl dipeptide (MDP) (InvivoGen) to allow for chitotrios-
idase induction. Chitotriosidase activity was determined in cell lysates
(prepared in PBS/0.1% Triton X-100 and sonicated for three cycles of
5 s on ice), using ﬂuorescent 4-MU-triacylchitotrioside (Sigma) [2].
Activities were calculated as nmol/mg h and expressed compared to
medium maturation. Alternatively, monocytes were matured for 8 days
in culture medium alone towards chitotriosidase expressing m/, which
were washed and further cultured in medium or stimulated with TLR
ligands or MDP. After 5, 24 and 48 h of culture chitotriosidase activity
was determined in cell lysates. m/ appearance was veriﬁed microscop-
ically and phenotypes were determined by FACS analysis with the
appropriate antibodies (anti-CD14, CD32, CD40, CD54, CD80,
CD86 and anti-HLA-DR).
Neutrophils (identiﬁed by Giemsa staining and subsequent micro-
scopic analysis indicating more than 95% purity) were seeded at 4 mil-
lion cells in a ﬁnal volume of 200 ll RPMI/0.5% BSA and stimulated
with TLR ligands, or MDP for 90 min. Activities of chitotriosidase
present in cell-free neutrophil supernatants were expressed on the
Y-axis with subtraction of medium induced spontaneous relea-
se.LY294002 was used to inhibit PI3kinase, SB302580 to inhibit p38blished by Elsevier B.V. All rights reserved.
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(all from Sigma, used at 50 lM). TLR ligands used are: LPS from Sal-
monella minnesota R 595 (Alexis; TLR-4 ligand), poly(I).poly(C) (pIC)
potassium salt (Amersham Biosciences; TLR-3 ligand), peptidoglycan
(pGN) from Staphylococcus aureus (Sigma; TLR-2/6 ligand),
PAM3CSK4 (InvivoGen; TLR-2/1) and Zymosan from Saccharomyces
cerevisiae (InvivoGen; TLR-2/6 ligand) and NOD2 ligand MDP. Sta-
tistical analysis was performed using the Student’s t-test; P < 0.05 was
considered signiﬁcant.2.2. Western blot analysis
Aliquots of 20 ll cell-free supernatants were analysed for chitotrios-
idase protein and neutrophil cell lysates were prepared in RIPA buﬀer
(150 mM NaCl, 30 mM Tris–HCl pH 7.4, 1 mM EDTA, 0.5% deoxy-
cholaat, 1 mM Na3VO4, 10 mM NaF, 0.5% Triton X-100), supple-
mented with protease inhibitor cocktail (Roche, Basel, Switzerland)
and PMSF. Following SDS–PAGE, proteins were transferred to ni-
tro-cellulose (Fischer Scientiﬁc, Pittsburgh, USA) and chitotriosidase
expression was assessed using a rabbit anti-chitotriosidase polyclonal
[8]. Signalling was determined with either rabbit anti-phospho-Akt
(Thr308), rabbit anti-phospho p38 MAP kinase, or rabbit anti-phos-
pho p44/p42 MAP kinase (ERK 1/2) (Cell signalling technology) and
for detection secondary HRP conjugated goat anti-rabbit IgG and en-A
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Fig. 1. Chitotriosidase release from human neutrophils stimulated with TLR
Y-axis activity is depicted as means ± S.D. n = 5. (E) Western blot analysis o
secretion upon TLR ligand stimulation.hanced chemiluminescence detection reagent was used (Amersham
Biosciences). Equal loading was conﬁrmed by mouse anti-b-actin
mAb (Sigma) or rabbit anti-eIF4E antibody (Cell signalling technol-
ogy).3. Results
3.1. Stimulation of human neutrophils with pGN, but not MDP,
triggers chitotriosidase release
Professional phagocytes, e.g. neutrophils and m/s, are
specialized innate immune cells recognizing invading patho-
gens. Chitotriosidase, a component of innate immunity, is
not expressed by monocytes, but is induced in m/s and present
in speciﬁc granules of neutrophils [2–4,6,7]. TLRs are known
to be involved in recognition and subsequent elimination of
pathogens by phagocytes [13]. Thus, we addressed the question
whether TLR-stimulation induces human neutrophilic chitotri-
osidase release contributing to chitotriosidase-mediated re-
sponses against pathogens. Human neutrophils express all
ten known TLRs except TLR-3 [18]. Here, we stimulated0
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ligands (Zymosan, or pGN), TLR-3 ligand pIC and TLR-4
ligand LPS (from S. minnesota). Chitotriosidase activity was
monitored in cell-free culture supernatants after 90 minutes
of TLR ligand stimulation using the 4-MU-chitotrioside sub-
strate. Incubation with TLR-3 ligand does not result in release
of chitotriosidase from speciﬁc granules of human neutrophils,
in line with the reported absence of TLR3 (data not shown).
TLR-4 stimulation (Fig. 1A) only results in modest enzyme re-
lease. Several TLR-2 ligands were used, with only minor
amounts of enzyme being released following stimulation with
PAM3CSK4 (TLR-2/1), or Zymosan (TLR-2/6) (Fig. 1B and
C). Of all ligands tested, only pGN induced potent dose-depen-
dent chitotriosidase release by human neutrophils (Fig. 1D).
The supernatant enzyme activity correlated with western blot
analysis results obtained using chitotriosidase speciﬁc antibod-
ies. The non-stimulated control group shows virtually no
release of chitotriosidase (Fig. 1E). Only the non-processed
50 kDa form was detected. To demonstrate the functionality
of the TLR ligands used, we looked at IL-8 secretion upon
stimulation by these ligands. The results of this analysis are
shown in Fig. 1F.
We next addressed which signalling cascades were involved in
this pGN-mediated induction of chitotriosidase secretion. A
time-dependent induction of PKB/Akt, p38 MAPK and ERK
1/2 phosphorylation was found, showing maximal phosphory-
lation after 15 min of stimulation (Fig. 2A). These data were
strengthened by studies using the p38 MAP kinase inhibitor
SB203580 and the PI3 kinase inhibitor LY294002, acting up-
stream of PKB/Akt. Chitotriosidase release induced by pGN
was reduced by half by each of these inhibitors while their com-
bined use completely reduced release to background levels, sug-
gesting the kinases are involved in pGN-induced release
(Fig. 2B). Inhibition of ERK 1/2, using PD98059, gave no sig-
niﬁcant inhibition, suggesting it is not essential for the pGN-
mediated release of chitotriosidase. Conﬂicting data exist with
respect to pGN recognition. It has been suggested that intracel-
lular NOD2, but not TLR-2, senses pGN fragment(s). Others,
however, claim the opposite: recognition occurs solely through
TLR-2 [19,20]. The minimal bioactive pGN motif MDP acti-
vates NOD2 and downstream signalling cascades [21,22]. We
found that MDP did not induce release of enzyme from neutro-
phils (Fig. 2C), although we conﬁrmed NOD2 expression at the
level of RNA and protein (data not shown). Functionality of
MDP was demonstrated by IL-8 release (Fig. 2D). This sug-
gests that release of chitotriosidase induced by pGN occurs
via TLR-2. Alternatively, a contaminant in the preparation is
responsible for release of the enzyme. In conclusion, stimula-
tion of human neutrophils with pGN results in a potent release
of chitotriosidase and probably operates directly via TLR-2.Fig. 2. Signalling pathways implied in pGN-induced release of
chitotriosidase from human neutrophils. (A) Western blot analysis of
phospho-PKB/Akt, phospho-p38MAP kinase, phospho-p44/p42MAP
kinase (ERK 1/2). (B) Inhibition of PI3 kinase and p38 MAP kinase
reduces release of chitotriosidase. (C) NOD-2 stimulation with MDP
does not induce chitotriosidase release. (D) IL-8 release upon MDP
stimulation. Activity is depicted as means ± S.D. n = 5, *P < 0.05;
***P < 0.001.3.2. Stimulation of human monocytes with TLR ligands and
MDP prevents induction of chitotriosidase
Human chitotriosidase was discovered as the m/-speciﬁc
chitinase [3–6]. The eﬀect of stimulation of human monocytes
with TLR ligands or MDP on chitotriosidase induction was
therefore studied. To this aim, monocytes, still requiring mat-
uration for enzyme induction, were matured with diﬀerent con-
centrations of TLR ligands or MDP.
Intracellular chitotriosidase activity was monitored over
time in PBS/Triton cell lysates; day 8 activities are depictedin Fig. 3. Monocytes matured with culture medium in the ab-
sence of additional stimuli showed a clear induction of enzyme
activity. However, LPS stimulation of TLR-4 completely
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5392 M. van Eijk et al. / FEBS Letters 581 (2007) 5389–5395prevented induction of chitotriosidase activity (Fig. 3A). All
other TLR ligands tested, i.e. pIC, pGN, Zymosan and
PAM3CSK4 dose-dependently inhibited induction of chitotri-
osidase release (Fig. 3B–E). MDP activation of NOD2 also
potently inhibited enzyme induction (Fig. 3F). The enzyme
activity data were conﬁrmed at the level of RNA by RT-
PCR and protein by western blot (data not shown).
In conclusion, stimulation of human monocytes with TLR
ligands or NOD2-activating MDP inhibits the chitotriosidase
induction normally seen during maturation of human mono-
cytes in medium only.3.3. Induction of chitotriosidase in mature chitotriosidase
expressing m/s by NOD2, but not by TLR activation
Thus, induction of chitotriosidase is inhibited when mono-
cytes are stimulated with TLR ligands and MDP. Can TLR li-
gands or MDP modulate existing chitotriosidase expression in
m/s as well? This was tested by stimulating matured m/s, cul-
tured for 8 days to allow chitotriosidase induction, with the
aforementioned stimuli or medium only. Upon washing the
m/s they were stimulated for 5, 24 or 48 h and chitotriosidase
activity was determined in cell lysates.
Functionality of TLR ligands used was conﬁrmed by TNF-a
ELISA. In line with earlier reports we observed a clear TNF-a
induction after 5 h in the presence of the TLR ligands used, ex-
cept with pIC (Fig. 4A). However, enzyme activity was not in-
duced at any time-point analysed; see Fig. 4B–D. Signiﬁcantinhibition was observed after 24 and 48 h of LPS, pIC or
pGN incubation (Fig. 4C and D). Overall, the chitotriosidase
activity data suggest that stimulation of m/s with TLR ligands
slightly inhibits enzyme expression.
Does stimulation of chitinase-expressing m/s with the
NOD2 ligand MDP inﬂuence chitotriosidase expression?
MDP functionality was conﬁrmed by ELISA ﬁrst. Clear induc-
tion of TNF-a was observed following m/ stimulation with
MDP; see Fig. 5A. Contrasting with TLR ligand stimulation,
we observed a signiﬁcant increase of chitotriosidase activity
after 5 h of stimulation with MDP (Fig. 5B). Signiﬁcant induc-
tion was not observed anymore upon 24 and 48 h of stimula-
tion, although some was still present after 24 h (Fig. 5C and
D).
In contrast to the observation that both TLR ligands and
MDP inhibited induction of chitotriosidase in monocytes,
stimulation of chitotriosidase-expressing m/s with TLR
ligands only slightly inﬂuences expression, while NOD2 activa-
tion clearly induces expression.4. Discussion
Chitotriosidase is a recently recognized component of innate
immune responses implicated in anti-fungal responses [1,2].
Evidence for involvement in anti-pathogenic responses is as
follows. Chitotriosidase activity is enhanced in sera of neo-
nates upon fungal, bacterial and viral infection and in plasma
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in visceral Leishmaniasis [4,17,23–25]. Virtually no hetero- or
homozygotes for the chitotriosidase gene defect are found in
the sub-Sahara, suggesting local advantages for active chitotri-
osidase, although other explanations for such diﬀerent allele
frequencies might exist [26]. The defective allele has a higher
risk of Gram-negative bacterial infection in children undergo-
ing therapy for AML [16]. Molecules of these pathogens can be
recognized by TLRs and NOD-2.
Here we have shown that chitotriosidase can be released
from neutrophils following stimulation with pGN, but not fol-
lowing stimulation of NOD-2 with MDP. A less pronounced
release was observed when TLR-2/1, TLR-2/6 or TLR-4 stim-
ulation was used. Both pGN and Zymosan induce chitotriosi-
dase release by neutrophils. They exert their inﬂuence via
TLR2/6, but Zymosan is much less potent. This could be
due to diﬀerences in cell surface receptor recognition. Zymosan
is also recognized via dectin-1 and this may explain diﬀerences
in release.
Neutrophils are present in the circulation and can be re-
cruited to sites of infection, or wound sites with potential risk
of pathogen entry. At these locations neutrophils can contrib-
ute to chitotriosidase-mediated innate immune responses, as it
is rapidly released from speciﬁc granules following TLR stim-
ulation. Recombinant human chitotriosidase targets fungi like
Candida albicans, Aspergillus fumigatus and Cryptococcus neo-
formans [1,2]. Such fungi are recognized by the immune system
through TLR-2 and TLR-4 [27]. Chitotriosidase can thus be
released from neutrophils, degrading chitin present in the fun-
gal cell walls.
Monocytes do not seem to contribute to acute, chitotriosi-
dase-dependent innate immune responses. Induction takes rel-
atively long and is inhibited by TLR ligands and MDP. Most
likely a common transcription factor, NFjB, negatively regu-
lates induction of chitotriosidase in monocytes. Possible
involvement of NFjB could indicate that chitotriosidase down
regulation is part of a more general response (altered matura-
tion) of monocytes to ligands such as LPS.
Stimulation of chitotriosidase-expressing m/ results in slight
down regulation of the enzyme, reaching a maximal inhibition
of 25%. But activity is far from eradicated and the remaining
activity will be suﬃcient for eﬃcient chitinase responses as out-
lined above.
Interestingly, MDP stimulated m/s had a 2-fold induction
of activity. This, combined with the observed release from neu-
trophils with bacterial TLR ligands and the presence of chito-
triosidase activity in sera of individuals undergoing bacterial
infections, could explain the association of compromised ge-
netic variants of the chitotriosidase allele with higher risk for
Gram-negative bacterial infection in children being treated
for AML [16,17]. All this suggests that chitotriosidase could
have more pleiotropic eﬀects in innate immune responses via
substrate(s) diﬀering from chitin.
In conclusion, chitotriosidase either released from speciﬁc
granules in neutrophils, or released by m/s, can contribute
to TLR and MDP-dependent innate immune responses re-
quired for the eradication of protozoan parasites, nematodes,
fungi and bacteria.
Acknowledgements: We would like to thank Drs de Vos and Lebre for
provision of reagents and critical reading of the manuscript.References
[1] Stevens, D.A., Brammer, H.A., Meyer, D.W. and Steiner, B.H.
(2000) Recombinant human chitinase. Curr. Opin. Anti-Infective
Investig. Drug 2, 399–404.
[2] van Eijk, M., van Roomen, C.P.A.A., Renkema, G.H., Bussink,
A.P., Andrews, L., Blommaart, E.F.C., Sugar, A., Verhoeven,
A.J., Boot, R.G. and Aerts, J.M.F.G. (2005) Characterization of
human phagocyte-derived chitotriosidase, a component of innate
immunity. Int. Immunol. 11, 1505–1512.
[3] Bussink, A.P., van Eijk, M., Renkema, G.H., Aerts, J.M. and
Boot, R.G. (2006) The biology of the Gaucher cell: the cradle of
human chitinases. Int. Rev. Cytol. 252, 71–128.
[4] Hollak, C.E., van Weely, S., van Oers, M.H. and Aerts, J.M.
(1994) Marked elevation of plasma chitotriosidase activity. A
novel hallmark of Gaucher disease. J. Clin. Invest. 93, 1288–1292.
[5] Renkema, G.H., Boot, R.G., Muijsers, A.O., Donker-Koopman,
W.E. and Aerts, J.M. (1995) Puriﬁcation and characterization of
human chitotriosidase, a novel member of the chitinase family of
proteins. J. Biol. Chem. 270, 2198–2202.
[6] Boot, R.G., Renkema, G.H., Strijland, A., van Zonneveld, A.J.
and Aerts, J.M. (1995) Cloning of a cDNA encoding chitotrios-
idase, a human chitinase produced by macrophages. J. Biol.
Chem. 270, 26252–26256.
[7] Escott, G.M. and Adams, D.J. (1995) Chitinase activity in human
serum and leukocytes. Infect. Immun. 63, 4770–4773.
[8] Renkema, G.H., Boot, R.G., Strijland, A., Donker-Koopman,
W.E., van den Berg, M., Muijsers, A.O. and Aerts, J.M. (1997)
Synthesis, sorting, and processing into distinct isoforms of human
macrophage chitotriosidase. Eur. J. Biochem. 244, 279–285.
[9] Tharanathan, R.N. and Kittur, F.S. (2003) Chitin – the undis-
puted biomolecule of great potential. Crit. Rev. Food Sci. Nutr.
43, 61–87.
[10] Boot, R.G., Blommaart, E.F., Swart, E., Ghauharali-van der
Vlugt, K., Bijl, N., Moe, C., Place, A. and Aerts, J.M. (2001)
Identiﬁcation of a novel acidic mammalian chitinase distinct from
chitotriosidase. J. Biol. Chem. 276, 6770–6778.
[11] Reese, T.A., Liang, H.E., Tager, A.M., Luster, A.D., Van
Rooijen, N., Voehringer, D. and Locksley, R.M. (2007) Chitin
induces accumulation in tissue of innate immune cells associated
with allergy. Nature 447, 92–96.
[12] Boot, R.G., Bussink, A.P., Verhoek, M., de Boer, P.A., Moor-
man, A.F. and Aerts, J.M. (2005) Marked diﬀerences in tissue-
speciﬁc expression of chitinases in mouse and man. J. Histochem.
Cytochem. 53, 1283–1292.
[13] Medzhitov, R. (2001) Toll-like receptors and innate immunity.
Nat. Rev. Immunol. 1, 135–145.
[14] Inohara, N. and Nunez, G. (2003) NODs: intracellular proteins
involved in inﬂammation and apoptosis. Nat. Rev. Immunol. 3,
371–382.
[15] Boot, R.G., Renkema, G.H., Verhoek, M., Strijland, A., Bliek, J.,
de Meulemeester, T.M., Mannens, M.M. and Aerts, J.M. (1998)
The human chitotriosidase gene. Nature of inherited enzyme
deﬁciency. J. Biol. Chem. 273, 25680–25685.
[16] Lehrnbecher, T., Bernig, T., Hanisch, M., Koehl, U., Behl, M.,
Reinhardt, D., Creutzig, U., Klingebiel, T., Chanock, S.J. and
Schwabec, D. (2005) Common genetic variants in the interleukin-
6 and chitotriosidase genes are associated with the risk for serious
infection in children undergoing therapy for acute myeloid
leukemia. Leukemia 19, 1745–1750.
[17] Labadaridis, I., Dimitriou, E., Theodorakis, M., Kafalidis, G.,
Velegraki, A. and Michelakakis, H. (2005) Chitotriosidase in
neonates with fungal and bacterial infections. Arch. Dis. Child
Fetal Neonatal Ed. 90, F531–F532.
[18] Fumitaka, H., Means, T.K. and Luster, A.D. (2003) Toll-like
receptors stimulate human neutrophil function. Blood 102, 2660–
2669.
[19] Travassos, L.H., Girardin, S.E., Philpott, D.J., Blanot, D.,
Nahori, M.A., Werts, C. and Boneca, I.G. (2004) Toll-like
receptor 2-dependent bacterial sensing does not occur via pepti-
doglycan recognition. EMBO Rep. 5, 1000–1006.
[20] Dziarski, R. and Gupta, D. (2005) Staphylococcus aureus pepti-
doglycan is a toll-like receptor 2 activator: a reevaluation. Infect.
Immun. 73, 5212–5216.
M. van Eijk et al. / FEBS Letters 581 (2007) 5389–5395 5395[21] Girardin, S.E., Boneca, I.G., Viala, J., Chamaillard, M., Labigne,
A., Thomas, G., Philpott, D.J. and Sansonetti, P.J. (2003) NOD2
is a general sensor of peptidoglycan through muramyl dipeptide
(MDP) detection. J. Biol. Chem. 278, 8869–8872.
[22] Gutierrez, O., Pipaon, C., Inohara, N., Fontalba, A., Ogura, Y.,
Prosper, F., Nunez, G. and Fernandez-Luna, J.L. (2002) Induc-
tion of NOD2 in myelomonocytic and intestinal epithelial cells via
nuclear factor-kappa B activation. J. Biol. Chem. 277, 41701–
41705.
[23] Michelakakis, H., Dimitriou, E. and Labadaridis, I. (2004) The
expanding spectrum of disorders with elevated plasma chitotrios-
idase activity: an update. J. Inherit. Metab. Dis. 27, 705–706.
[24] Labadaridis, J., Dimitriou, E., Costalos, C., Aerts, J., van Weely,
S., Donker-Koopman, W.E. and Michelakakis, H. (1998) Serialchitotriosidase activity estimations in neonatal systemic candidi-
asis. Acta Paediatr. 87, 605.
[25] Barone, R., Simpore, J., Malaguarnera, L., Pignatelli, S. and
Musumeci, S. (2003) Plasma chitotriosidase activity in acute
Plasmodium falciparum malaria. Clin. Chim. Acta. 331, 79–
85.
[26] Malaguarnera, L., Simpore, J., Prodi, D.A., Angius, A., Sassu,
A., Persico, I., Barone, R. and Musumeci, S. (2003) A 24-bp
duplication in exon 10 of human chitotriosidase gene from the
sub-Saharan to the Mediterranean area: role of parasitic diseases
and environmental conditions. Gene Immun. 4, 570–574.
[27] Roeder, A., Kirschning, C.J., Rupec, R.A., Schaller, M. and
Korting, H.C. (2004) Toll-like receptors and innate antifungal
responses. Trend Microbiol. 12, 44–49.
